4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-027582
Chief Executive Officer sold 13,000 shares at an average $83.04 ($1,079,501)
- Chief Executive Officer acquired 13,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schenkein David P Chief Executive Officer | 2018-05-01 | Option exercise | +13,000 | $0.30 | $3,933 | 13,000 | D |
| Schenkein David P Chief Executive Officer | 2018-05-01 | Sale | −10,086 | $82.88 | $835,928 | 2,914 | D |
| Schenkein David P Chief Executive Officer | 2018-05-01 | Sale | −2,814 | $83.56 | $235,138 | 100 | D |
| Schenkein David P Chief Executive Officer | 2018-05-01 | Sale | −100 | $84.35 | $8,435 | 0 | D |
| Derivatives | |||||||
| Schenkein David P Chief Executive Officer | 2018-05-01 | Option exercise · Stock option (right to buy) | −13,000 | 65,567 | D | ||
| Open-market sales · 13,000 sh · avg $83.04 · $1,079,501 | |||||||
Loading xslF345X03/doc4.xml…